These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28939419)

  • 1. Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies.
    Samara MT; Goldberg Y; Levine SZ; Furukawa TA; Geddes JR; Cipriani A; Davis JM; Leucht S
    Lancet Psychiatry; 2017 Nov; 4(11):859-867. PubMed ID: 28939419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA; Levine SZ; Tanaka S; Goldberg Y; Samara M; Davis JM; Cipriani A; Leucht S
    JAMA Psychiatry; 2015 Jan; 72(1):14-21. PubMed ID: 25372935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania.
    Baker RW; Milton DR; Stauffer VL; Gelenberg A; Tohen M
    J Affect Disord; 2003 Jan; 73(1-2):147-53. PubMed ID: 12507747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC; DelBello MP; Landry J; Usher RW
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
    Berk M; Ng F; Wang WV; Tohen M; Lubman DI; Vieta E; Dodd S
    J Affect Disord; 2008 Sep; 110(1-2):126-34. PubMed ID: 18280579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    J Affect Disord; 2012 Feb; 136(3):476-84. PubMed ID: 22134043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
    Sachs GS; Greenberg WM; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Affect Disord; 2015 Mar; 174():296-302. PubMed ID: 25532076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials.
    Fornaro M; Stubbs B; De Berardis D; Perna G; Valchera A; Veronese N; Solmi M; Ganança L
    Int J Mol Sci; 2016 Feb; 17(2):241. PubMed ID: 26891297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.
    Tohen M; McDonnell DP; Case M; Kanba S; Ha K; Fang YR; Katagiri H; Gomez JC
    Br J Psychiatry; 2012 Nov; 201(5):376-82. PubMed ID: 22918966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Nonresponse in the Antipsychotic Treatment of Acute Mania: A Criterion for Reconsidering Treatment? Results From an Individual Patient Data Meta-Analysis.
    Welten CC; Koeter MW; Wohlfarth TD; Storosum JG; van den Brink W; Gispen-de Wied CC; Leufkens HG; Denys DA
    J Clin Psychiatry; 2016 Sep; 77(9):e1117-e1123. PubMed ID: 27780320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of olanzapine in the treatment of bipolar mania with mixed features defined by DSM-5.
    Tohen M; McIntyre RS; Kanba S; Fujikoshi S; Katagiri H
    J Affect Disord; 2014 Oct; 168():136-41. PubMed ID: 25046739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.
    Muralidharan K; Ali M; Silveira LE; Bond DJ; Fountoulakis KN; Lam RW; Yatham LN
    J Affect Disord; 2013 Sep; 150(2):408-14. PubMed ID: 23735211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M; Kryzhanovskaya L; Carlson G; Delbello M; Wozniak J; Kowatch R; Wagner K; Findling R; Lin D; Robertson-Plouch C; Xu W; Dittmann RW; Biederman J
    Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.